Demopulos Gregory A Md

Avg. Two Year Performance

No purchase track record
(17%) Avg. Sale Return
(8%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return6%(5%)(25%)(54%)(17%)
Sale Success Rate1 of 40 of 40 of 40 of 40 of 4

Omeros Corp

Drugs » Drug Manufacturers - Major

Chairman, CEO & President, Director:

Holdings: 2.15M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--